Description
3-Oxa-8-azabicyclo[3.2.1]octane (CAS No. 280-07-9) is a bicyclic organic compound with the molecular formula C6H11NO. This heterocyclic structure features both nitrogen and oxygen atoms within its rigid bicyclo[3.2.1]octane framework, making it a valuable scaffold in medicinal chemistry and pharmaceutical research. The compound is available in high purity (≥95%) and is supplied as a clear, colorless to pale yellow liquid under standard conditions. Its unique structural properties lend it to applications in asymmetric synthesis, ligand design, and as a precursor for complex heterocycles. Proper storage at 2-8°C under inert atmosphere is recommended to ensure long-term stability.
Properties
- CAS Number: 280-07-9
- Complexity: 84.5
- IUPAC Name: 3-oxa-8-azabicyclo[3.2.1]octane
- InChI: InChI=1S/C6H11NO/c1-2-6-4-8-3-5(1)7-6/h5-7H,1-4H2
- InChI Key: MNILDQSRDHCFJG-UHFFFAOYSA-N
- Exact Mass: 113.084063974
- Molecular Formula: C6H11NO
- Molecular Weight: 113.16
- SMILES: C1CC2COCC1N2
- Topological: 21.3
- Monoisotopic Mass: 113.084063974
- Synonyms: 3-oxa-8-azabicyclo[3.2.1]octane, 280-07-9, 3-OXA-8-AZA-BICYCLO[3.2.1]OCTANE, MFCD18250273, (1R,5S)-3-oxa-8-azabicyclo[3.2.1]octane, SCHEMBL55211, SCHEMBL55587, SCHEMBL328886, DTXSID20570351, MNILDQSRDHCFJG-UHFFFAOYSA-N, AKOS006350951, SB19955, DS-17600, SY039547, DB-025165, CS-0054659, EN300-82710, P12236, F2147-2297
Application
3-Oxa-8-azabicyclo[3.2.1]octane serves as a key intermediate in the synthesis of pharmacologically active compounds, particularly those targeting neurological receptors. Its constrained bicyclic structure is utilized in developing chiral ligands for asymmetric catalysis. Researchers also employ this heterocycle as a building block for novel drug candidates with potential analgesic or anti-inflammatory properties.
If you are interested or have any questions, please contact us at support@atomfair.com
Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.


Reviews
There are no reviews yet.